215600.KS · 신라젠

South Korea · RS rating 23 · As of 2026-10-14

Price2,180.00 KRW
1-day change-1.6%
RS rating (overall / 1M / 3M / 12M)23 / 28 / 54 / 29
StageDeclining
Composite / Minervini / CANSLIM score20 / 9 / 30
Industry group (rank)Medical-Biomed/Biotech (95)
EPS growth Q/Q-11.1%
Sales growth Q/Q-21.3%
Distance from 52-week high+56.2%
Market cap (USD)$241.5M
Open South Korea in the interactive screener